基本信息
views: 21
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
杨勇,男,中国药科大学基础医学与临床药学学院院长,新药安全评价研究中心主任,教授(二级)、博士生导师,享受国务院政府特殊津贴。入选国家“万人计划”科技创新领军人才、“百千万工程国家级人才”和科技部“创新人才推进计划中青年科技创新领军人才”,被授予“有突出贡献中青年专家”称号。主要研究方向为肿瘤发病机制研究与新药创制,目前已在国际重要学术期刊如PNAS、Gut、Hepatology、Cancer Research等发表SCI论文60余篇,其中第一作者或通讯作者40余篇,SCI期刊累计他引超过3000次,单篇论文最高他引超过200次;申请发明专利8项,其中已授权5项。累计承担20余项新药临床前研究,获得临床批件或备案多项。先后主持国家自然科学基金“重大研究计划”,主持科技部“十二五重大新药创制专项”和“十三五重大新药创制专项” 等十余项国家级课题,获得首届江苏省杰出青年基金。2016年获得“上海市科技进步一等奖”,2015年荣获“中国药理学会施维雅青年药理学家奖”。
Research Interests
Papers共 228 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Yanting Lin, Rui Gao,Dongquan Jing,Yiming Liu, Huijuan Da,Lutz Birnbaumer,Yong Yang,Xinghua Gao,Zhenhua Gao,Qiuhua Cao
Frontiers in pharmacology (2024): 1392328-1392328
Emerging Microbes & Infectionsno. 1 (2024): 2309985-2309985
Hao Yin,Menghan Zhang,Congying Gu, Zhenyu Li, Chenyan Hao, Junhui Wang, Lulu Tian, Kang Xu, Xiangyu Hu, Liqin Ming, Min Zhang,Zhanbo Wang,
Journal of Medicinal Chemistryno. 13 (2024): 10743-10773
Qiuhua Cao, Mingrui Zhao,Yali Su,Siliang Liu,Yanting Lin, Huijuan Da,Chongxiu Yue,Yiming Liu, Dongquan Jing,Qixiang Zhao,Ning Liu, Juan Du,
crossref(2024)
Shuang Feng,Duowei Wang, Yanyan Jin,Shi Huang, Tong Liang, Wei Sun, Xiuli Du, Luoyi Zhuo, Chun Shan, Wenbo Zhang, Tian Jing,Sen Zhao,
CELL REPORTSno. 6 (2024): 114300-114300
MOLECULAR CANCERno. 1 (2024)
Clinical Cancer Bulletinno. 1 (2024): 1-13
Lulu Huang,Shun Zhang,Tongyi Zhao,Ting Cai, Lingling Bu, Zhenhua Di, Yujie Zhang,Chen Yang,Yong Yang,Ang Lin
Emerging microbes & infectionspp.2392661-2392661, (2024)
Mengya Zhao,Beiying Dai,Xiaodong Li,Yixin Zhang,Chun Qiao, Yaru Qin, Zhao Li,Qingmei Li,Shuzhen Wang,Yong Yang,Yijun Chen
eLife (2024)
Load More
Author Statistics
#Papers: 226
#Citation: 6065
H-Index: 45
G-Index: 73
Sociability: 7
Diversity: 4
Activity: 125
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn